ARCHIVES

Imbruvica Improves PFS, OS In Phase III CLL Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Kathy Giusti Named One of The TIME’s 100 Most Influential People

April 22, 2011

First CCOP 3 Returns In; Payline Not Yet Determined; Goes to NCAB On Jan. 30

January 26, 1990

Sunitinib May Be Associated With Cardiac Toxicity

January 25, 2008

CCRAC Members Say Practicing Physicians Do Not Use Cancer Prevention Methods

August 24, 1979

Obituary: Martin Abeloff, 65, Cancer Center Director At Johns Hopkins.

September 21, 2007

Appropriations: Senate Committee Approves 4.5 Percent Cut To Defense Dept. Cancer Research Funding

July 25, 2014